Melanoma: Clinical sciences

1,375views

test

00:00 / 00:00

Melanoma: Clinical sciences

Core acute presentations

Assessments

USMLE® Step 2 questions

0 / 3 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

A 47-year-old man presents to the dermatology clinic with concerns about a pigmented lesion on his left upper arm. He mentions that he first noticed the lesion about 6 months ago, but in the past two months, it appears to have grown and darkened in color. He works as a construction worker and often spends prolonged periods outdoors without sun protection. Past medical history is significant for hypertension controlled with hydrochlorothiazide. Family history is noncontributory. Temperature is 36.8°C (98.2°F), blood pressure is 130/85 mm Hg, pulse is 72/min, respiratory rate is 16/min, and oxygen saturation is 99% on room air. Skin examination reveals a 1.5 cm asymmetric lesion with an irregular border and with a number of variable colors. An excisional biopsy of the lesion reveals atypical melanocytes with hyperchromatic nuclei with a Breslow thickness of 0.7 mm, without ulceration, along with inadequate margins. There is no evidence of regional lymphadenopathy on examination. Which of the following is the best next step in management?  

Transcript

Watch video only

Melanoma is a very serious type of skin cancer arising from pigment-producing cells called melanocytes. It’s the fifth most common cancer in the United States and is associated with high rates of mortality. Melanoma can develop anywhere on the body and has a high rate of spread, so early diagnosis and treatment are key to improve overall outcomes.

Alright, when a patient presents with a chief concern suggesting melanoma, the first step is to obtain a focused history and physical. Typically, patients will report noticing a skin lesion with recent changes in size, color, or developing associated symptoms like pruritus. Sometimes they might even notice bleeding from the lesion.

A patient may also experience systemic symptoms that are alarming for malignancy, including fevers, chills, fatigue, bone pain, or weight loss. History might reveal risk factors like a personal or family history of cutaneous malignancy or immunosuppression, as well as fair skin, a tendency to sunburn, chronic sun exposure, or previous sunburns.

On a physical exam, you’ll typically find a pigmented skin lesion like a macule, plaque, or nodule with an irregular border. Make sure to do a full body exam checking for other similar lesions or nevi.

Important findings can be summarized by the mnemonic ABCDE, which stands for Asymmetry; Border irregularities; Color variations, such as brown or black spots with other colors like red, blue, gray, or white; Diameter, often larger than 6 mm; and Evolution, like changes in size, shape, or color, depigmentation, development of streaks, pseudopods or irregular vascularity.

Some of the suspicious characteristics you should look for include bleeding, crusting, or ulceration. If you see a lesion that differs from other nevi, it is called the "ugly duckling sign". Last but not least, remember to check regional lymph nodes for lymphadenopathy, which is concerning for possible metastasis. If you see these findings, be very suspicious of melanoma.

Here’s a clinical pearl! Primary care settings usually perform naked-eye physical examination, while dermatologic settings may also use support diagnostic tools like a dermatoscope, which acts as a magnifying glass to help evaluate the lesion in more detail.

The best way to confirm the diagnosis is with an excisional or incisional biopsy of the lesion, which will provide histopathological information. When possible, an excisional or complete biopsy should be performed to remove the entire lesion. This is done by taking 1 to 3 mm margin of surrounding normal skin, including the depth of the thickest part of the lesion. However, this might not be feasible if the lesion is large or located on the face, palms, or ears.

In these cases, incisional, or partial, biopsy can be performed. The important aspect of incisional biopsy is to ensure the full depth of the lesion is obtained within the sample, which is needed to determine the tumor depth.

Time for a clinical pearl! If you suspect melanoma, never obtain a shave biopsy, as it doesn’t obtain the full depth of the lesion, leading to inaccurate staging and inadequate treatment!

Okay, histopathology findings consistent with melanoma include atypical melanocytes with hyperchromatic nuclei, or other abnormal nuclei or nucleoli characteristics, in addition to asymmetric, poorly circumscribed nests of melanocytes. If findings aren’t consistent with melanoma, consider an alternative diagnosis; but if these findings are present, you can confirm your diagnosis of melanoma.

Here’s a clinical pearl! There are four main subtypes of melanoma. Superficial spreading melanoma is the most common one, accounting for 60% of cases, followed by nodular melanoma, which makes up 15 to 30% of cases. The last two types, lentigo maligna melanoma and acral lentiginous melanoma, are much less common. Other rare subtypes include amelanotic, dermoplastic, and spitzoid melanoma.

Now that you’ve made your diagnosis, your next step is to assess the Breslow thickness as well as ulceration. The Breslow thickness examines the lesion’s depth, meaning its vertical growth in millimeters from the most superficial aspect of the tumor, usually within the epidermis, down to the deepest layer. Depth, along with ulceration, are very important characteristics to help determine the appropriate treatment.

Sources

  1. "NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2" J Natl Compr Canc Netw (2021)
  2. "Guidelines of care for the management of primary cutaneous melanoma" J Am Acad Dermatol (2019)
  3. "The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care" Expert Rev Anticancer Ther (2018)
  4. "Early detection of melanoma: reviewing the ABCDEs" J Am Acad Dermatol (2015)
  5. "AJCC Cancer Staging Manual, 8th ed." Springer International Publishing (2017)
  6. "Patterns of detection in patients with cutaneous melanoma" Cancer (2000)
  7. "Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma" Ann Surg (1970)
  8. "The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway" Arch Pathol Lab Med (2020)
  9. "Role of Surgery for Metastatic Melanoma" Surg Clin North Am (2020)
  10. "Inhibition of mutated, activated BRAF in metastatic melanoma" N Engl J Med (2010)
  11. "Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual" CA Cancer J Clin (2017)
  12. "Role of Surgery in Combination with Immunotherapy" Surg Oncol Clin N Am (2019)
  13. "Targeted Therapy in Advanced Melanoma with Rare BRAF Mutations" J Clin Oncol (2019)
  14. " Invasive Melanoma, Histopathology Reporting Guide, 2nd edition" International Collaboration on Cancer Reporting (2019)
  15. "American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture" Ophthalmology (2015)
  16. "Protocol for the examination of excision specimens from patients with melanoma of the skin" College of American Pathologists
  17. "Cancer Statistics" CA Cancer J Clin (2021)
  18. "Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation" Cancer Treat Rev (2016)